![Declan Doogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Declan Doogan
Directeur/Membre du Conseil chez
TENAX THERAPEUTICS, INC.
Fortune : 33 087 $ au 30/06/2026
Profil
Le Dr Declan Doogan, MD, est un président indépendant de Biohaven Pharmaceutical Holding Co. Ltd, président de Portage Pharma Ltd, directeur indépendant de Portage Biotech, Inc, président de Spinifex Pharmaceuticals Pty Ltd, président de Causeway Therapeutics Ltd, président de Celleron Therapeutics Ltd et président de iOX Therapeutics Ltd. Il est membre du conseil d'administration de Tenax Therapeutics, Inc, Kleo Pharmaceuticals, Inc, Juvenescence Ltd, Portage Biotech, Inc, Intensity Therapeutics, Inc et The Pulmonary Vascular Research Institute. Le Dr Doogan a été précédemment employé comme directeur médical et vice-président exécutif par Prometheus Laboratories, Inc. et comme directeur externe par Sosei Group Corp. et comme directeur médical en chef par Amarin Corp. Plc, chef du développement mondial chez Pfizer Inc. et professeur à la Harvard T.H. Chan School of Public Health, professeur à l'université de Kitasato, premier vice-président et chef du développement mondial chez Pfizer (St. Louis), premier vice-président de la R&D clinique chez Pfizer Europe International Ltd. et premier vice-président de la R&D clinique chez Pfizer Japan, Inc. et professeur à l'école de médecine de l'université de Glasgow. Il a également siégé au conseil d'administration de Heptares Therapeutics Ltd. Il est titulaire d'un doctorat de l'université de Glasgow et d'un doctorat de l'université du Kent.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TENAX THERAPEUTICS, INC. 0,01 % | 08/04/2026 | 2 274 ( 0,01 % ) | 33 087 $ | 30/06/2026 |
Postes actifs de Declan Doogan
| Sociétés | Poste | Début |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 25/02/2021 |
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Directeur/Membre du Conseil | - |
Apterna Ltd. | Directeur/Membre du Conseil | - |
Mediqventures Ltd.
 Mediqventures Ltd. Finance/Rental/LeasingFinance Provides financing services for life science technologies | Corporate Officer/Principal | - |
BYOMass, Inc.
 BYOMass, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses | Directeur/Membre du Conseil | 27/10/2021 |
Causeway Therapeutics Ltd.
 Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops novel microRNA therapies for the treatment of common musculoskeletal and age-related diseases | Président | - |
Kleo Pharmaceuticals, Inc.
 Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule immunotherapies to treat patients with cancer as well as other life-threatening diseases | Directeur/Membre du Conseil | 01/11/2019 |
The Pulmonary Vascular Research Institute
 The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a global medical research charity | Directeur/Membre du Conseil | - |
Anciens postes connus de Declan Doogan
| Sociétés | Poste | Fin |
|---|---|---|
| ALPHA COMPUTE CORP | Directeur Général | 06/05/2019 |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Declan Doogan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
29
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 29 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Tenax Therapeutics, Inc.
 Tenax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes pharmaceutical therapeutic products | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
AlphaTON Capital Corp.
 AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Nxera Pharma Co., Ltd.
 Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
Pfizer Europe International Ltd.
 Pfizer Europe International Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Europe International Ltd. is an Irish company. | Health Technology |
Spinifex Pharmaceuticals Pty Ltd.
 Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drug candidates for the treatment & management of pain | Health Technology |
Topix Pharmaceuticals, Inc.
 Topix Pharmaceuticals, Inc. Household/Personal CareConsumer Non-Durables Manufactures and markets therapeutic and cosmetic skin care products | Consumer Non-Durables |
Pfizer Japan, Inc.
 Pfizer Japan, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets medical drugs & vaccines | Commercial Services |
Kitasato University
 Kitasato University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kent
 University of Kent Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Health Technology |
Portage Pharma Ltd.
 Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
The Pulmonary Vascular Research Institute
The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as a global medical research charity | Commercial Services |
University of Glasgow School of Medicine
 University of Glasgow School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iOx Therapeutics Ltd.
 iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Health Technology |
Mediqventures Ltd.
Mediqventures Ltd. Finance/Rental/LeasingFinance Provides financing services for life science technologies | Finance |
Kleo Pharmaceuticals, Inc.
Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule immunotherapies to treat patients with cancer as well as other life-threatening diseases | Commercial Services |
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
BYOMass, Inc.
BYOMass, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses | Commercial Services |
Causeway Therapeutics Ltd.
Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops novel microRNA therapies for the treatment of common musculoskeletal and age-related diseases | Health Technology |
Apterna Ltd. |
